Literature DB >> 17560693

Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.

Nizar Souayah1, Abu Nasar, M Fareed K Suri, Adnan I Qureshi.   

Abstract

Using the data from Vaccine Adverse Event Reporting System, we present 54 reports of Guillain-Barre Syndrome (GBS) after vaccination that occurred in United States in 2004. In 38 of the patients, GBS occurred within 6 weeks. The highest number (n=31) of GBS was observed in patients receiving influenza vaccine followed by hepatitis vaccine (n=9), 1 patient died and 10 patients were disabled following the event. We conclude that vaccines other than influenza vaccine can be associated with GBS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560693     DOI: 10.1016/j.vaccine.2007.03.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

Review 1.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

2.  "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events.

Authors:  David Evans; Simon Cauchemez; Frederick G Hayden
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

3.  Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndrome.

Authors:  S Usuki; K Taguchi; S A Thompson; P B Chapman; R K Yu
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

Review 4.  Guillain-Barré syndrome and variants.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-02-19       Impact factor: 3.806

5.  Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.

Authors:  Sirarat Sarntivijai; Zuoshuang Xiang; Kerby A Shedden; Howard Markel; Gilbert S Omenn; Brian D Athey; Yongqun He
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

6.  No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies.

Authors:  David J Wang; David A Boltz; Janet McElhaney; Jonathan A McCullers; Richard J Webby; Robert G Webster
Journal:  Influenza Other Respir Viruses       Date:  2011-09-29       Impact factor: 4.380

7.  Transient oculomotor palsy after influenza vaccination: short report.

Authors:  Diogo Fraxino de Almeida; Adilson Teixeira Teodoro; Rafael de Figueiredo Radaeli
Journal:  ISRN Neurol       Date:  2011-04-26

8.  Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.

Authors:  Mohammed A El-Bayoumi; Ahmed M El-Refaey; Alaa M Abdelkader; Mohamed M A El-Assmy; Angi A Alwakeel; Hanem M El-Tahan
Journal:  Crit Care       Date:  2011-07-11       Impact factor: 9.097

9.  Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.

Authors:  Sophie R Bader; Sonja Kothlow; Sascha Trapp; Susanne Cn Schwarz; Hans-Christian Philipp; Steffen Weigend; Ahmad R Sharifi; Rudolf Preisinger; Wolfgang Schmahl; Bernd Kaspers; Kaspar Matiasek
Journal:  J Neuroinflammation       Date:  2010-01-28       Impact factor: 8.322

10.  Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.

Authors:  Almurtada Razok; Abdullah Shams; Ahmed Almeer; Muhammad Zahid
Journal:  Ann Med Surg (Lond)       Date:  2021-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.